Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Willis Towers Watson Public Limited Company (0Y4Q.L)
London, GB
Willis Towers Watson Public Limited Company operates as a global advisory, broking, and solutions enterprise, structured into two main divisions: Health, Wealth and Career, and Risk and Broking. Under its Health, Wealth and Career segment, the company delivers comprehensive services including actuarial support, benefits plan design, and administrative oversight for traditional pension and retirement savings programs. It also provides consulting, brokerage, and administrative services for health and group benefit plans, alongside benefits outsourcing solutions. This division further offers strategic counsel, data analytics, software, and specialized products to assist clients with their total rewards and talent management challenges. The Risk and Broking segment provides expert risk advisory services, insurance brokerage, and consulting across diverse sectors such as property and casualty, aerospace, construction, and marine. This division also extends investment consulting and discretionary asset management to insurance and reinsurance companies. Its extensive offerings encompass insurance consulting and technology solutions, risk and capital management strategies, advanced pricing and predictive modeling, comprehensive financial and regulatory reporting, detailed financial and capital modeling, merger and acquisition support, outsourcing capabilities, and broader business management services. Additionally, it engages in wholesale insurance broking for both retail and wholesale brokers, while also providing underwriting, capital management, capital market advisory, and general brokerage services. Beyond these core segments, Willis Towers Watson facilitates primary medical and ancillary benefit exchanges and offers outsourcing solutions to active employees and retirees in both group and individual markets. The company also manages various healthcare and reimbursement accounts, including Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs), Flexible Spending Accounts (FSAs), and other consumer-directed options. Established in 1828, the company is headquartered in London, United Kingdom. Previously known as Willis Group Holdings Public Limited Company, it officially adopted its current name, Willis Towers Watson Public Limited Company, in January 2016.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.17% | -3.60% | -9.73% | -9.55% | -21.87% | -24.52% | -17.51% | +10.18% | -5.20% | +63.78% | +63.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Brokers: +8.0%-2.3% Q1'26: +8.6% (vs Q1'25)
-
EPS growth Insurance - Brokers: +30.1%+1,793.8% ★ Q1'26: +32.6% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Brokers: +26.6%+11.9% Q1'26: -2.7% (vs Q1'25)
-
EBIT margin Insurance - Brokers: +19.1%+23.3% ★ Q1'26: +18.6% (vs Q1'25)
-
ROIC Insurance - Brokers: +6.4%+15.4% ★ Q1'26: +11.6% (vs Q1'25)
-
Share dilution Insurance - Brokers: -0.6%-2.9% ★ Q1'26: -5.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Brokers: -0.02×2.76× Q1'26: 3.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 1 EPS Ana. |
Dec 2027 13 Rev. Ana. 1 EPS Ana. |
Dec 2028 8 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.29B
est.
|
3.39B
est.
|
3.53B
est.
|
3.46B
est: 3.50B (-1.1%)
|
3.63B
est: 3.70B (-1.9%)
|
3.77B
est: 3.86B (-2.3%)
|
3.83B
est: 3.84B (-0.2%)
|
7.85B
est: 7.94B (-1.2%)
|
8.15B
est: 8.11B (+0.5%)
|
8.49B
est: 8.50B (-0.2%)
|
9.04B
est: 8.97B (+0.7%)
|
8.61B
est: 9.27B (-7.1%)
|
9.00B
est: 9.40B (-4.2%)
|
8.86B
est: 8.83B (+0.4%)
|
9.48B
est: 9.44B (+0.5%)
|
9.93B
est: 9.93B (+0.0%)
|
9.71B
est: 9.62B (+1.0%)
|
10.42B
10.20B – 10.53B
+8.3% YoY
|
11.00B
10.62B – 11.29B
+5.5% YoY
|
11.63B
11.31B – 11.85B
+5.8% YoY
|
| EBITDA |
438.57M
est.
|
535.27M
est.
|
597.79M
est.
|
373.00M
est: 219.69M (+69.8%)
|
830.00M
est: -354.59M (+334.1%)
|
841.00M
est: 531.65M (+58.2%)
|
787.00M
est: 537.09M (+46.5%)
|
1.79B
est: 825.26M (+116.9%)
|
1.97B
est: 892.25M (+121.0%)
|
2.04B
est: 1.02B (+99.1%)
|
2.03B
est: 1.42B (+42.5%)
|
2.15B
est: 1.85B (+16.0%)
|
2.07B
est: 1.94B (+6.7%)
|
1.88B
est: 2.01B (-6.7%)
|
2.42B
est: 2.08B (+16.6%)
|
2.58B
est: 2.44B (+5.6%)
|
2.68B
est: 2.37B (+12.8%)
|
2.57B
2.51B – 2.60B
+8.3% YoY
|
2.71B
2.62B – 2.78B
+5.5% YoY
|
2.87B
2.79B – 2.92B
+5.8% YoY
|
| EBIT |
572.63M
est.
|
714.38M
est.
|
784.21M
est.
|
301.00M
est: 390.90M (-23.0%)
|
686.00M
est: -221.22M (+410.1%)
|
695.00M
est: 651.53M (+6.7%)
|
687.00M
est: 653.19M (+5.2%)
|
878.00M
est: 883.18M (-0.6%)
|
1.10B
est: 352.05M (+211.3%)
|
982.00M
est: 543.51M (+80.7%)
|
1.36B
est: 854.40M (+59.2%)
|
1.38B
est: 1.38B (-0.2%)
|
1.42B
est: 1.45B (-1.8%)
|
1.31B
est: 1.50B (-12.6%)
|
1.93B
est: 1.55B (+24.5%)
|
2.12B
est: 1.89B (+12.2%)
|
2.26B
est: 1.84B (+22.8%)
|
1.99B
1.95B – 2.01B
+8.3% YoY
|
2.10B
2.03B – 2.16B
+5.5% YoY
|
2.22B
2.16B – 2.26B
+5.8% YoY
|
| Net Income |
345.40M
est.
|
450.86M
est.
|
473.86M
est.
|
-446.00M
est: 201.88M (-320.9%)
|
365.00M
est: -472.08M (+177.3%)
|
362.00M
est: 380.49M (-4.9%)
|
373.00M
est: 365.46M (+2.1%)
|
340.00M
est: 771.49M (-55.9%)
|
489.00M
est: 424.88M (+15.1%)
|
851.00M
est: 598.28M (+42.2%)
|
1.04B
est: 734.00M (+42.2%)
|
996.00M
est: 1.08B (-8.0%)
|
4.22B
est: 1.14B (+271.2%)
|
1.07B
est: 1.18B (-9.3%)
|
1.06B
est: 1.22B (-13.3%)
|
-98.00M
est: 1.64B (-106.0%)
|
1.61B
est: 1.68B (-4.4%)
|
1.93B
1.86B – 1.98B
+15.2% YoY
|
2.19B
2.11B – 2.25B
+13.3% YoY
|
2.49B
2.40B – 2.55B
+13.5% YoY
|
| SGA |
1.87B
est.
|
1.88B
est.
|
1.95B
est.
|
—
est: 2.07B (-100.0%)
|
—
est: 2.62B (-100.0%)
|
—
est: 2.30B (-100.0%)
|
142.00M
est: 2.34B (-93.9%)
|
—
est: 4.77B (-100.0%)
|
—
est: 4.91B (-100.0%)
|
—
est: 5.23B (-100.0%)
|
—
est: 5.41B (-100.0%)
|
—
est: 5.70B (-100.0%)
|
—
est: 5.98B (-100.0%)
|
—
est: 6.20B (-100.0%)
|
—
est: 6.40B (-100.0%)
|
5.52B
est: 1.10B (+401.3%)
|
—
est: 1.07B (-100.0%)
|
1.16B
1.13B – 1.17B
+8.3% YoY
|
1.22B
1.18B – 1.26B
+5.5% YoY
|
1.29B
1.26B – 1.32B
+5.8% YoY
|
| EPS |
2.72
est.
|
2.77
est.
|
2.83
est.
|
-6.83
est: 2.62 (-360.3%)
|
5.37
est: 2.77 (+93.7%)
|
5.32
est: 2.45 (+117.3%)
|
5.49
est: 6.52 (-15.8%)
|
2.47
est: 7.72 (-68.0%)
|
3.67
est: 8.42 (-56.4%)
|
6.46
est: 9.78 (-33.9%)
|
10.16
est: 10.93 (-7.0%)
|
7.66
est: 11.50 (-33.4%)
|
15.02
est: 12.82 (+17.1%)
|
9.54
est: 13.39 (-28.7%)
|
10.05
est: 14.10 (-28.7%)
|
-0.96
est: 16.71 (-105.7%)
|
16.38
est: 16.96 (-3.4%)
|
19.54
18.83 – 20.02
+15.2% YoY
|
22.14
21.34 – 22.68
+13.3% YoY
|
25.12
24.21 – 25.74
+13.5% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | Citigroup | Neutral | Buy | Upgrade |
| 2026-05-05 | Mizuho | Outperform | Outperform | Maintain |
| 2026-05-04 | UBS | Buy | Buy | Maintain |
| 2026-05-01 | BMO Capital | Market Perform | Outperform | Upgrade |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-09 | Krasner Andrew Jay | Officer | M-Exempt | A | Ordinary Shares, nominal value $0.000304635 per share | 192 | 0.00 | — | 8,163 | — | ↗ |
| 2024-08-13 | Krasner Andrew Jay | Officer | A-Award | A | Restricted Share Unit | 6 | 0.00 | — | 595 | — | ↗ |
| 2024-08-13 | Hess Carl Aaron | Director / Officer | A-Award | A | Restricted Share Unit | 64 | 0.00 | — | 7,748 | — | ↗ |
| 2024-08-13 | Banas Kristy D | Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 909 | 275.86 | 250.8K | 6,148 | — | ↗ |
| 2024-07-22 | Pullum Anne | Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 1,405 | 263.13 | 369.7K | 14,207 | — | ↗ |
| 2024-07-22 | Hess Carl Aaron | Director / Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 2,161 | 263.13 | 568.6K | 77,560 | — | ↗ |
| 2024-07-22 | Gebauer Julie Jarecke | Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 1,669 | 263.13 | 439.2K | 72,253 | — | ↗ |
| 2024-07-22 | Garrard Adam | Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 1,876 | 263.13 | 493.6K | 14,277 | — | ↗ |
| 2024-07-22 | Furman Matthew | Officer | F-InKind | D | Ordinary Shares, nominal value $0.000304635 per share | 1,804 | 263.13 | 474.7K | 33,015 | — | ↗ |
| 2024-07-22 | Clarke Lucy | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-15 | Thomson-Hall Pamela | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 5 | — | ↗ |
| 2024-07-15 | Qureshi Imran Ahmed | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 12 | — | ↗ |
| 2024-07-15 | Pullum Anne | Officer | A-Award | A | Restricted Share Unit | 7 | 0.00 | — | 2,086 | — | ↗ |
| 2024-07-15 | Kurpis Joseph Stephen | Officer | A-Award | A | Restricted Share Unit | 1 | 0.00 | — | 428 | — | ↗ |
| 2024-07-15 | Krasner Andrew Jay | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 2 | 0.00 | — | 21 | — | ↗ |
| 2024-07-15 | Hess Carl Aaron | Director / Officer | A-Award | A | Restricted Share Unit | 28 | 0.00 | — | 8,413 | — | ↗ |
| 2024-07-15 | Gebauer Julie Jarecke | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 14 | — | ↗ |
| 2024-07-15 | Garrard Adam | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 15 | — | ↗ |
| 2024-07-15 | Furman Matthew | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 11 | — | ↗ |
| 2024-07-15 | Faber Alexis | Officer | A-Award | A | Ordinary Shares, nominal value $0.000304635 per share | 5 | 0.00 | — | 6,493 | — | ↗ |
| 2024-07-15 | Banas Kristy D | Officer | A-Award | A | Dividend Equivalent Rights- 2022 RSU Award | 1 | 0.00 | — | 9 | — | ↗ |
| 2024-07-10 | Qureshi Imran Ahmed | Officer | A-Award | A | Restricted Share Unit | 54 | 0.00 | — | 2,573 | — | ↗ |
| 2024-07-10 | Pullum Anne | Officer | A-Award | A | Restricted Share Unit | 0 | 0.00 | — | 837 | — | ↗ |
| 2024-07-10 | Kurpis Joseph Stephen | Officer | A-Award | A | Restricted Share Unit | 6 | 0.00 | — | 283 | — | ↗ |
| 2024-07-10 | Krasner Andrew Jay | Officer | A-Award | A | Restricted Share Unit | 4 | 0.00 | — | 587 | — | ↗ |
| 2024-07-10 | Hess Carl Aaron | Director / Officer | A-Award | A | Restricted Share Unit | 12 | 0.00 | — | 7,659 | — | ↗ |
| 2024-07-10 | Gebauer Julie Jarecke | Officer | A-Award | A | Restricted Share Unit | 64 | 0.00 | — | 22,976 | — | ↗ |
| 2024-07-10 | Furman Matthew | Officer | A-Award | A | Restricted Share Unit | 0 | 0.00 | — | 2,416 | — | ↗ |
| 2024-07-10 | Faber Alexis | Officer | A-Award | A | Restricted Share Unit | 0 | 0.00 | — | 971 | — | ↗ |
| 2024-07-10 | Banas Kristy D | Officer | A-Award | A | Restricted Share Unit | 49 | 0.00 | — | 875 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carl A. Hess CERA | Chief Executive Officer & Director | 4M | male |
| Andrew Jay Krasner | Chief Financial Officer & Co-head of Corporate Development | 2M | male |
| Julie Jarecke Gebauer | President of Health, Wealth & Career | 2M | female |
| Lucy Clarke | President of Risk & Broking | 2M | female |
| Matthew S. Furman | General Counsel | 2M | male |
| Kristy D. Banas | Chief Human Resources Officer and Head of Marketing & Communication | — | female |
| Alexis Faber | Chief Operating Officer | — | female |
| William Jay Dubinsky | MD & Head of Insurance-Linked Securities - WCMA | — | male |
| Claudia De La Hoz | Head of Investor Relations | — | female |
| Eric Arnaldo Latalladi | Global Head of Technology | — | male |
| Gianmarco Tosti | Head of Corporate Risk & Broking and Italy Country Manager | — | male |
| Joseph Stephen Kurpis | Principal Accounting Officer & Controller | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0Y4Q.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
